Longeveron says Phase 2b trial shows laromestrocel improves physical condition in age-related frailty patients
Bitget2026/09/30 20:07Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Longeveron highlighted Phase 2b results showing its laromestrocel cell therapy improved physical condition in age-related frailty patients versus placebo.
- Those findings were already published in February 2026, supporting efforts to secure funding and other revenue opportunities for a longevity program.
- A new exploratory analysis from its Phase 2a Alzheimer’s study was posted as a preprint, indicating reduced brain inflammation with treatment.
- The Alzheimer’s analysis has not been peer reviewed, leaving clinical and commercial implications uncertain.
- Longeveron received a $1 million XPRIZE Healthspan Milestone 2 award to support a future competition clinical trial.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longeveron Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609301605PRIMZONEFULLFEED9837091) on September 30, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
BICO completes integration of Cellenion into SCIENION, retires Cellenion brand
Bitget•2026/10/02 05:00
Japanese Yen draws support from hot Tokyo CPI as USD bulls await US NFP report
FXStreet•2026/10/02 04:30
A global bond market sell-off sweeps across the world, pushing the dollar to a 17-month high; the euro becomes the hardest-hit currency.
On Friday, the US dollar hovered near a 17-month high and is set to rise for the third consecutive week.
智通财经•2026/10/02 03:41
Japan’s Katayama says will beef up efforts to promote version of doge review of subsidies, funds
FXStreet•2026/10/02 02:39
Crypto prices
More
Bitcoin
BTC
$86,028.36
+2.19%
Ethereum
ETH
$2,717.98
+0.16%
Tether USDt
USDT
$0.9996
+0.02%
BNB
BNB
$777.06
+0.83%
XRP
XRP
$1.52
+0.62%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$122.07
+2.32%
TRON
TRX
$0.3343
-0.93%
Zcash
ZEC
$1,385.69
-3.54%
Hyperliquid
HYPE
$89.09
+0.03%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now